H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Archives of Otolaryngology - Head and Neck Surgery

• Publication date

  1994-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/ARCHOTOL.1994.01880310059011PMID 7912510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules.

  1994cited by this paper
• Prevalence of RAS oncogene mutation in head and neck carcinomas.

  1992cited by this paper
• Cooperation between oncogenes.

  1991cited by this paper
• Activation of ras oncogenes preceding the onset of neoplasia.

  1990cited by this paper
• Molecular pathologic study of human papillomavirus infection in inverted papilloma and squamous cell carcinoma of the nasal cavities and paranasal sinuses

  1990cited by this paper
• HPV-18 immortalization of human keratinocytes.

  1989cited by this paper
• Association of papillomavirus with cancers of the head and neck.

  1989cited by this paper
• Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras.

  1989cited by this paper
• Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells

  1988cited by this paper
• Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.

  1988cited by this paper
• Oncogene activation in chemical carcinogenesis.

  1988cited by this paper
• The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

  1988cited by this paper
• Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.

  1988cited by this paper
• Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas.

  1987cited by this paper
• ras genes.

  1987cited by this paper
• Prevalence of ras gene mutations in human colorectal cancers

  1987cited by this paper
• Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells

  1986cited by this paper
• Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.

  1986cited by this paper
• A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient.

  1984cited by this paper
• Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue

  1983cited by this paper
• The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors.

  1983cited by this paper

• Unveiling Oral Cancer's Molecular Blueprint: A Novel Classification to Guide Precision Therapy.

  2025cites this paper
• Mechanisms of Cetuximab Resistance and How to Overcome It

  2021cites this paper
• Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor radioresistance

  2021cites this paper
• Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations

  2021cites this paper
• Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor radioresistance

  2021cites this paper
• Correlation between Decreased Nuclear Factor Kappa Beta (NFKβ), Kras, and Braf Genes’ Expression and Enhanced Chemosensitivity of Human Squamous Cell Carcinoma Cells to 5-fluorouracil and/or Mesenchymal Stem Cells-derived Microvesicles

  2021cites this paper
• Cooperation between oncogenic Ras and p53 stimulates JAK/STAT non-cell autonomously to promote Ras tumor radioresistance

  2020cites this paper
• Genetic alterations in human papillomavirus-associated oropharyngeal squamous cell carcinoma of patients with treatment failure.

  2019cites this paper
• Differential characteristics of human papillomavirus-positive and human papillomavirus-negative oral carcinomas

  2019influential citation
• Inhibition of BMP signaling overcomes acquired resistance to cetuximab in oral squamous cell carcinomas.

  2018cites this paper
• Signature of genetic associations in oral cancer

  2017cites this paper
• Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma

  2017cites this paper
• The Akt/mTOR pathway is activated in verrucous carcinoma of the oral cavity.

  2016cites this paper
• Molecular Aspects of Head and Neck Cancer Therapy.

  2015cites this paper
• THÈSE POUR LE DOCTORAT EN PHARMACIE

  2015cites this paper
• Impact du polymorphisme des récepteurs FcγRIIA et FcγRIIIA couplé à la fonctionnalité des cellules Natural Killer sur la réponse clinique des patients atteints de carcinome épidermoïde des voies aéro-digestives supérieures, traités par Cetuximab

  2015cites this paper
• Signaling pathways in HPV‐associated cancers and therapeutic implications

  2015cites this paper
• RAS/PI3K Crosstalk and Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma

  2014cites this paper
• mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations

  2014cites this paper
• Overcoming Resistance to EGFR inhibitor in Head and Neck Squamous Cell Carcinoma ( HNSCC )

  2014cites this paper
• The role of human papillomavirus in oral squamous cell carcinoma: myth and reality

  2014cites this paper
• Four major factors regulate phosphatidylinositol 3-kinase signaling pathway in cancers induced by infection of human papillomaviruses.

  2014cites this paper
• HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells

  2014cites this paper
• Squamous cell carcinoma variants of the upper aerodigestive tract: a comprehensive review with a focus on genetic alterations.

  2014cites this paper
• Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma.

  2014cites this paper
• Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance.

  2013cites this paper
• Efficacy of cetuximab and panitumumab in oral squamous cell carcinoma cell lines: prognostic value of MAGE-A subgroups for treatment success.

  2013cites this paper
• Verrucous carcinoma of the head and neck – not a human papillomavirus-related tumour?

  2013cites this paper
• Molecular markers of response and resistance to EGFR inhibitors in head and neck cancers.

  2013cites this paper
• Cell Signalings and the Communications in Head and Neck Cancer

  2012cites this paper
• Ras oncogenes in oral cancer: the past 20 years.

  2012cites this paper
• The molecular pathogenesis of head and neck squamous cell carcinoma.

  2012cites this paper
• Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer

  2012cites this paper
• Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib.

  2011cites this paper
• Fulfilling the Promises: Contribution of Genomes for the Changing Dentistry

  2011cites this paper
• Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer.

  2011cites this paper
• Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010.

  2011cites this paper
• Malignant Neoplasms of the Oral Cavity

  2010cites this paper
• Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.

  2010cites this paper
• Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors

  2009cites this paper
• Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model.

  2009cites this paper
• Review article: The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis versus proliferation.

  2008cites this paper
• Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy

  2008cites this paper
• The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship.

  2008cites this paper
• Genotypic determination by PCR-RFLP of human papillomavirus in normal oral mucosa, oral leukoplakia and oral squamous cell carcinoma samples in Madrid (Spain).

  2008cites this paper
• Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma.

  2007cites this paper
• Chemoprevention of squamous cell carcinoma of the head and neck

  2007cites this paper
• Animal models in oral cancer research.

  2006cites this paper
• Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene

  2006cites this paper
• BASIC SCIENCE REVIEW

  2006cites this paper
• Use of tissue autofluorescence in the detection of oral premalignant lesions with high risk molecular patterns

  2006cites this paper
• Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence.

  2005cites this paper
• Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers.

  2005cites this paper
• Molecular assessment of former cancer sites predicts second oral malignancy

  2005cites this paper
• Prevention of head and neck cancer: current status and future prospects.

  2004cites this paper
• Advances in chemoprevention of head and neck cancer.

  2004cites this paper
• Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers

  2004cites this paper
• Advances in Brief Inducible Activation of Oncogenic Kras Results in Tumor Formation in the Oral Cavity

  2004cites this paper
• Inducible Activation of Oncogenic K-ras Results in Tumor Formation in the Oral Cavity

  2004cites this paper
• Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer

  2003cites this paper
• Oncogenes and Tumor Suppressor Genes in Oral or Head and Neck Squamous Cell Carcinoma

  2003cites this paper
• The investigation of toluidine blue and loss of heterozygosity patterns in oral premalignant lesions

  2002cites this paper
• Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission.

  2002cites this paper
• Advanced diagnostic methods in oral and maxillofacial pathology. Part II: immunohistochemical and immunofluorescent methods.

  2002cites this paper
• Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma.

  2002cites this paper
• Deregulated cyclooxygenase-2 expression in oral premalignant tissues.

  2002cites this paper
• Differential expression of ras signal transduction mediators in verrucous and squamous cell carcinomas of the upper aerodigestive tract.

  2001cites this paper
• Oral cancer in the molecular age.

  2001cites this paper
• Reinitiated expression of EJras transgene in targeted epidermal cells of transgenic rabbits by cottontail rabbit papillomavirus infection.

  2001cites this paper
• Conversion of normal to malignant phenotype: telomere shortening, telomerase activation, and genomic instability during immortalization of human oral keratinocytes.

  2001cites this paper
• Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997.

  2001cites this paper
• Prospects for using transgenic resistance to insects in crop improvement

  2000cites this paper
• Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations.

  2000cites this paper
• Genetic instability and oral cancer

  2000cites this paper
• Genetic alterations in Ki-ras and Ha-ras genes in juvenile nasopharyngeal angiofibromas and head and neck cancer.

  1999influential citation
• Immunophenotype of mutant ras p21 and early response to radiotherapy in cancer of the uterine cervix.

  1999cites this paper
• Low detection rate of HPV in oral and laryngeal carcinomas.

  1998cites this paper
• Medical oncology in the management of head and neck cancers

  1998cites this paper
• Metastasierungsverhalten und Prognose von verrukösen Karzinomen - Literaturübersicht und retrospektive Studie -

  1998cites this paper
• Morphological assessment of malignant potential of epithelial hyperplastic lesions.

  1997cites this paper
• HPV-associated diseases of oral mucosa.

  1997cites this paper
• Comparative study of invasive squamous cell carcinoma and verrucous carcinoma of the oral cavity: expression of bcl-2, p53, and Her-2/neu, and indexes of cell turnover.

  1997cites this paper
• Role of human papillomaviruses in cancer of the respiratory and upper digestive tract.

  1997cites this paper
• Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN), with reference to oral carcinoma (review).

  1997cites this paper
• Molecular changes in oral cancer may reflect aetiology and ethnic origin.

  1996cites this paper
• Häufigkeit von Punktmutationen in Ki-ras Codon 12 und 13 bei Plattenepithelkarzinomen der Kopf-Hals-Region*

  1996cites this paper
• Hereditary and environmental risk factors; clinical and laboratory risk matters for head and neck, especially oral, cancer and precancer.

  1996cites this paper
• New aspects of oral viral diseases.

  1996cites this paper
• Oncogenes and growth factor receptors as diagnostic and prognostic markers in precancers and cancers of the oral mucosa.

  1996cites this paper
• Mutant ras epitopes as targets for cancer vaccines.

  1996cites this paper
• [Incidence of point mutations in Ki-ras codon 12 and 13 in squamous epithelial carcinomas of the head-neck region].

  1996cites this paper
• Combined Epstein-Barr Virus and Human Papillomavirus Infection in Nasopharyngeal Carcinoma

  1995cites this paper